內視鏡逆行性造影市場規模、佔有率、成長分析（按產品類型、程序、最終用戶和地區）- 2025 年至 2032 年產業預測

Endoscopic Retrograde Cholangiopancreatography Market Size, Share, and Growth Analysis, By Product Type (Endoscopes, Endotherapy Devices), By Procedure (Biliary Sphincterotomy, Biliary Stenting), By End Users, By Region - Industry Forecast 2025-2032

出版日期: 2025年04月02日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計 2023 年全球內視鏡逆行性造影市場規模將達到 15 億美元，從 2024 年的 16.5 億美元成長到 2032 年的 34.8 億美元，預測期內（2025-2032 年）的複合年成長率為 9.8%。

微創手術的日益普及導致對內視鏡逆行性胰造影(ERCP) 手術的需求大幅增加，這使得該領域在未來幾年將迎來強勁成長。 ERCP 之所以受歡迎，是因為它比傳統手術具有優勢，包括恢復時間更短、併發症發生率更低。美國癌症協會最近發布的數據預計 2023 年美國將新增約 41,210 例肝癌病例，凸顯了這些進展的迫切性。這項統計數據凸顯了對複雜診斷和治療方案日益成長的需求，並強調了在 ERCP 市場持續投資和創新的重要性。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）
  主要企業簡介
  - 奧林巴斯株式會社（日本）
  - 美國康美德公司
  - 富士軟片控股株式會社（日本）
  - 豪雅株式會社（日本）
  - 波士頓科學公司（美國）
  - 強生公司（美國）
  - 美敦力公司（愛爾蘭）
  - 庫克醫療（美國）
  - STERRIS PLC（美國）
  - TeleMed Systems Inc.（美國）
  - DCC Healthcare (Medi-Globe GmbH)（愛爾蘭）
  - 惠格醫療器材有限公司 (中國)
  - 索諾斯凱醫療公司（中國）
  - KARL STORZ SE & Co. KG（德國）
  - Ambu A/S（丹麥）
  - B.Braun Melsungen AG（德國）
  - 賓得醫療（日本）
  - 日立有限公司（日本）
  - 佳能醫療系統株式會社（日本）
  - 索尼公司（日本）

結論和建議

簡介目錄

Product Code: SQMIG35A2748

Global Endoscopic Retrograde Cholangiopancreatography Market size was valued at USD 1.5 billion in 2023 and is poised to grow from USD 1.65 billion in 2024 to USD 3.48 billion by 2032, growing at a CAGR of 9.8% during the forecast period (2025-2032).

The rising popularity of minimally invasive surgical techniques has led to a significant uptick in the demand for endoscopic retrograde cholangiopancreatography (ERCP) procedures, positioning this sector for robust growth in the coming years. The preference for ERCP is driven by its benefits, such as shorter recovery periods and decreased complication rates compared to traditional surgery. Recent data from the American Cancer Society highlights the urgency for such advancements, as the U.S. anticipates approximately 41,210 new liver cancer cases in 2023. This statistic underlines the increasing necessity for sophisticated diagnostic and therapeutic options, reinforcing the importance of ongoing investments and innovations within the ERCP market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Endoscopic Retrograde Cholangiopancreatography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Endoscopic Retrograde Cholangiopancreatography Market Segments Analysis

Global Endoscopic Retrograde Cholangiopancreatography Market is segmented by Product Type, Procedure, End Users and region. Based on Product Type, the market is segmented into Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices and Others. Based on Procedure, the market is segmented into Biliary Sphincterotomy, Biliary Stenting, Biliary Dialtation, Pancreatic Sphincterotomy, Pancreatic Duct Stenting and Pancreatic Duct Dilatation. Based on End Users, the market is segmented into Hospitals, Ambulatory Surgery Centers & Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Endoscopic Retrograde Cholangiopancreatography Market

The global endoscopic retrograde cholangiopancreatography (ERCP) market is propelled by the increasing demand for advanced diagnostic and therapeutic solutions targeting the pancreas, liver, gallbladder, and bile ducts. ERCP is a sophisticated procedure that combines luminal endoscopy and fluoroscopic imaging, allowing for effective identification and treatment of pancreatobiliary disorders. This technique involves the use of a flexible, illuminated endoscope, which navigates through the digestive tract for direct visualization of critical organs, while simultaneously capturing X-ray images. The ability to provide comprehensive assessments and interventions drives the growth of the ERCP market, catering to the rising needs of healthcare providers worldwide.

Restraints in the Global Endoscopic Retrograde Cholangiopancreatography Market

The growth of the Global Endoscopic Retrograde Cholangiopancreatography market is being restrained by stringent regulatory guidelines enforced by governing bodies in various countries, which create obstacles for the introduction of new technologies. Adhering to these regulations necessitates extensive testing and compliance with safety and efficacy standards, resulting in a complicated and time-consuming approval process for novel medical innovations. Despite these regulatory challenges, there are positive developments within the market. Notably, the increase in disposable income, particularly in developing nations, has emerged as a significant driver of market expansion, indicating potential for future growth despite existing constraints.

Market Trends of the Global Endoscopic Retrograde Cholangiopancreatography Market

The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) market is set to flourish, driven by innovative strategic initiatives from leading industry players. Notable activities, such as product launches, mergers, and acquisitions, are transforming the landscape. For instance, the April 2022 partnership between Olympus and EndoClot Plus, which introduced the EndoClot PHS, exemplifies the market's focus on enhancing therapeutic endoscopic solutions. This collaboration emphasizes the shift towards nonthermal, nontraumatic techniques for efficient hemostasis in gastrointestinal procedures. As healthcare providers increasingly prioritize advanced and effective treatments, the ERCP market is poised for substantial growth, reflecting a commitment to improving patient outcomes and enhancing procedural safety.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies

Global Endoscopic Retrograde Cholangiopancreatography Market Size by Product Type & CAGR (2025-2032)

Market Overview
Endoscopes
Endotherapy Devices
- Sphincterotomes
- Lithotripter
- Stents
- Cannulas
- Forceps
- Snares
- Catheters
- Guiding Wires
- Balloons
- Baskets
Visualization Systems
Energy Devices
Others

Global Endoscopic Retrograde Cholangiopancreatography Market Size by Procedure & CAGR (2025-2032)

Market Overview
Biliary Sphincterotomy
Biliary Stenting
Biliary Dialtation
Pancreatic Sphincterotomy
Pancreatic Duct Stenting
Pancreatic Duct Dilatation

Global Endoscopic Retrograde Cholangiopancreatography Market Size by End Users & CAGR (2025-2032)

Market Overview
Hospitals
Ambulatory Surgery Centers & Clinics
Others

Global Endoscopic Retrograde Cholangiopancreatography Market Size & CAGR (2025-2032)

North America (Product Type, Procedure, End Users)
- US
- Canada
Europe (Product Type, Procedure, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Procedure, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Procedure, End Users)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Procedure, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CONMED Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HOYA Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STERRIS PLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TeleMed Systems Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DCC Healthcare (Medi-Globe GmbH) (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Huger Medical Instrument Co. Ltd (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SonoScape Medical Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KARL STORZ SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ambu A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PENTAX Medical (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hitachi Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sony Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments